U.S. Tissue Engineering Markets

The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, hernia repair and breast reconstruction. The dynamic market for tissue engineering is growing steadily over the last decade and continues to grow. A thorough understanding of revenue, procedure and demand analysis is provided for different segments of the study. Tissue engineering market is highly competitive, with more than 50 manufacturers selling hundreds of different products. Since this market is a highly evolving space, there is plenty room for smaller entrepreneurial companies to offer innovative products in the market.

U.S. Tissue Engineering Markets

Market Overview

• Technology advancement in the tissue engineering field and better understanding of market needs have been a major boost to growth of this market sector.
• Tissue engineering has shown promise as an important solution to treat tissue and organ failure. It addresses these problems by implanting natural, synthetic, or semisynthetic tissues that are fully functional from the start, or that grow into the required functionality.
• Initial efforts have focused on skin equivalents for treating burns, but an increasing number of tissue types are now being engineered, as well as biomaterials and scaffolds used as delivery systems.
• Quality control of the materials used in various surgical applications is a key challenge for the tissue engineering industry.
• End-user ease of use, patient comfort, and recovery times are important features for tissue engineering materials. Surgeon/physician education will play a major role in extending the adoption rate in this market.
• It is a highly competitive market ranging from major medical device manufacturers to smaller niche technology innovators. Study pertains to the U.S. markets.
• Period: 2008 to 2018.
• Base Year: 2011.
• Forecast Period of Study: 2011 to 2018.

Introduction and Scope

• The scope of this research service primarily includes tissue engineering products that are used to treat chronic wounds, burns, and surgical applications like hernia repair, heart valves, and breast reconstruction.
• The tissue engineering market is marked by extensive R&D. Companies take several years to commercially launch products in the market. In the 1980s, R&D in tissue engineering and biomaterials took off. As part of this interest, several biomedical engineering departments were established at major universities around the world.
• Wound repair is a key application for tissue engineering products. Although most applications focus on the use of artificial skin to treat burns, different disease conditions are also benefiting.
• A fundamental understanding of tissue differentiation mechanisms that might be harnessed for the development of tissue-engineered products is required to advance treatment of care in the tissue engineering arena.
• Technical advances in the various components of the industry will contribute to market growth. One component is the availability of biomaterials that act as scaffolds for tissue repair and reconstruction, or for the deposition of engineered tissues and cells preceding implantation.
• For the biological component of tissue engineering, rapid advances are being made in identifying new cell types for use in tissue regeneration. An establishment of a consensus quality control program to ensure that tissue engineering products work and are safe to use is required.
• The tissue engineering market is highly competitive, with more than xx manufacturers selling hundreds of different products. Since this market is a highly evolving space, there is plenty of room for smaller entrepreneurial companies to offer innovative products in the market.
• Though companies have been growing organically, growth by mergers and acquisitions has been a trend in this market, with major competitors growing largely through acquisitions of smaller companies.
• Major manufacturers in the market are Medtronic, Cook, Lifecell, W. L. Gore, Integra, and others.

Drivers Explained

Advanced Products and Technologies Drive Adoption and Revenues in the Market

• Xenograft mesh will experience rapid adoption for complex surgeries in all sectors of hernia repair over the next five years.
• Tissue engineering-type surgeries have gained popularity in the last decade. These repairs offer faster recovery times for the patient and have shown high recurrence rates.
• Sales of premium-priced advanced products will mainly fuel revenue expansion.
• Biologics have gained a lot of interest in the last decade. But companies have not been able to provide adequate data to support their claims and show the clinical community that biologics are better than synthetics. Biologics have much higher prices than do synthetics, and if manufacturers are able to drive adoption of these products in the market, revenues are bound to increase.
• As successful cases of surgery are reported, people are more prone to opt for premium options, thus increasing the price of overall repair.
• Going forward, we can expect many technologically superior products to be launched in the tissue engineering space. As their adoption rate increases, so will the revenue in the market. Technology will be a strong growth contributor in the marketplace.

Table Of Contents

Notes on Methodology 6

Market Introduction and Segmentation 7-11

Drivers and Restraints 12-19

Wound Care Market 20-51

Surgery Market 52-99

Certification 100

Legal Disclaimer 101

The Frost & Sullivan Story 102-106

List Of Figures
Wound Care Market: Prevalence of Chronic Wounds (Global), 2007-2016 24
Wound Care Market: Products of Chronic Wounds (U.S.), 2011 27-30
Wound Care Market: Product List for Burns (U.S.), 2011 49-50
Cardiovascular Surgery Market: Percent of Company Market Share by Revenue for Heart Valves (U.S.), 2011 59
Organ Regeneration Surgery Market: Liver Product List (U.S.), 2011 72
Organ Regeneration Surgery Market: Number of Donors (U.S.), 2007-2010 75
Organ Regeneration Surgery Market: Number of Transplants (U.S.), 2007-2010 76
Hernia Repair Surgery Market: Synthetic Meshes Market Share Analysis (U.S.), 2011 88
Hernia Repair Surgery Market: Biologic Meshes Product List (U.S.), 2011 89
Hernia Repair Surgery Market: Biologic Meshes Market Share Analysis (U.S.), 2011 92
Neurology Surgery Market: Number of Diagnoses (U.S.), 2001-2009 96
Breast Reconstruction Surgery Market: Number of Diagnoses (U.S.), 2001-2009 99

List Of Charts

Tissue Engineering Markets: Market Segmentation by Application (U.S.), 2011 8
Tissue Engineering Markets: Key Market Drivers and Restraints (U.S.), 2012-2018 12
Wound Care Market: Procedure by ICD-9 Codes for Burns (U.S.), 2001-2009 40
Wound Care Market: Revenue Forecast for Burns (U.S.), 2008-2018 42
Cardiovascular Surgery Market: Revenue Forecast for Heart Valves (U.S.), 2008-2018 57
Cardiovascular Surgery Market: Percent of Company Market Share by Revenue for Heart Valves (U.S.), 2011 59
Cardiovascular Surgery Market: Procedure by ICD-9 Codes for Myocardial Infarction (U.S.), 2001-2009 62
Cardiovascular Surgery Market: Revenue Forecast for Myocardial Infarction Products (U.S.), 2008-2018 63
Cardiovascular Surgery Market: Diagnoses Analysis for Diabetes Mellitus (U.S.), 2001-2009 67
Organ Regeneration Surgery Market: Reasons for Liver Transplantation (U.S.), 2011 70
Organ Regeneration Surgery Market: Diagnoses Analysis for Acute Hepatic Failure (U.S.), 2001-2009 73
Organ Regeneration Surgery Market: Meniscus Repair Revenue Forecast (U.S.), 2008-2018 79
Organ Regeneration Surgery Market: Cartilage Repair Revenue Forecast (U.S.), 2008-2018 82
Hernia Repair Surgery Market: Synthetic Meshes Revenue Forecast (U.S.), 2008-2018 86
Hernia Repair Surgery Market: Synthetic Meshes Market Share Analysis (U.S.), 2011 88
Hernia Repair Surgery Market: Biologic Meshes Revenue Forecast (U.S.), 2008-2018 90
Hernia Repair Surgery Market: Biologic Meshes Market Share Analysis (U.S.), 2011 92
Neurology Surgery Market: Number of Diagnoses (U.S.), 2001-2009 95
Breast Reconstruction Surgery Market: Number of Diagnoses (U.S.), 2001-2009 98